Alumnus’ Journey Took Him from the Bullpen to Neuroscience PhD
Will Rosellini MBA’03, MS’08 was not your typical professional baseball player.
When he was pitching for the Arizona Diamondbacks, he, like most pitchers, was fascinated by the mechanics of a perfect curveball or fastball. But he was also captivated by the specific neuroscience and neuromuscular aspects of throwing a baseball, which isn’t something talked about much in the bullpen.
Will Rosellini MBA'03, MS'08
Rosellini, a PhD candidate in the School of Behavioral and Brain Sciences (BBS), is unique when it comes to the pace and scope of his accomplishments. He has six advanced degrees spanning business, law and science. He has also already founded and sold one telemedical company and raised $10 million in private equity funding for his latest venture, MicroTransponder Inc., which in collaboration with BBS researchers, is developing novel treatments for a variety of neurological disorders. And, he will soon earn his doctorate in neuroscience, doing research in the efficacy and safety of a new form of electrical neurostimulation.
“UT Dallas was founded by visionaries on the leading edge of electronics,” Rosellini said, “And I've been fascinated by the notion of shrinking electronic devices to integrate into the nervous system.”
The first clinical product Rosellini is working on through his translational neurotechnology research, and the company he leads is a vagus nerve stimulator to treat tinnitus and post-stroke motor rehabilitation.
“My goal is to help restore one million patients worldwide who have neurological deficits. I know that’s pretty audacious, but neurostimulation can have benefits anywhere the body uses electricity to communicate between cells, and that spans a wide range of neurological disorders.”
Media Contact: The Office of Media Relations, UT Dallas, (972) 883-2155, [email protected].